Citius Oncology - About the company
Citius Oncology is a public company based in Cranford (United States), founded in 2023. It operates as a Developer of targeted oncology therapies, including FDA-approved treatment for CTCL. The company has 3304 active competitors, including 1117 funded and 780 that have exited. Its top competitors include companies like Jazz Pharmaceuticals, BeiGene and Sana Biotechnology.
Company Details
Developer of targeted oncology therapies, including FDA-approved treatment for CTCL. The company’s primary asset is approved for adults with relapsed or refractory CTCL after prior systemic therapy. Intellectual property protections include orphan drug designation, complex technology, trade secrets, and pending patents for immuno-oncology use.
- Website
- citiusonc.com
- Social
- Email ID
- *****@citiusonc.com
- Phone Number
- +1 **********
Key Metrics
Founded Year
2023
Location
Cranford, United States
Stage
Public
Ranked
1076th among 3304 active competitors
Employee Count
23 as on Sep 30, 2026
Exit Details
Public
Legal entities associated with Citius Oncology
Citius Oncology is associated with 1 legal entity given below:
Legal Entity Name | Date of Incorporation | Revenue | Latest Employee Count | Documents |
|---|---|---|---|---|
Citius Oncology, Inc. CIN: 1851484 , United States, Active | - | - | - |
Citius Oncology's IPO details
Citius Oncology got listed on Oct 13, 2022.
Click here to take a look at Citius Oncology's IPO in detail
Sign up to download Citius Oncology's company profile
Citius Oncology's funding and investors
Citius Oncology is a funded company.
Citius Oncology's founders and board of directors
Founder? Claim ProfileCitius Oncology's employee count trend
Citius Oncology has 23 employees as of Sep 26. Here is Citius Oncology's employee count trend over the years:
Uncover Citius Oncology's growth story! Sign up today!
Access Tracxn on any website
Install Tracxn ExtensionOur Google Chrome extension lets you view company details while browsing their websites
Citius Oncology's Competitors and alternates
Top competitors of Citius Oncology include Jazz Pharmaceuticals, BeiGene and Sana Biotechnology. Here is the list of Top 10 competitors of Citius Oncology, ranked by Tracxn score:
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!
Rank | Company Details | Short Description | Total Funding | Investors | Tracxn Score |
|---|---|---|---|---|---|
1st |  Jazz Pharmaceuticals 2003, Dublin (Ireland), Public | Developer of novel biopharmaceutical medicines for unmet medical needs | $265M | 81/100 | |
2nd |  BeiGene 2010, Cambridge (United States), Public | Developer of targeted and immune-oncology drugs against cancer | $172M | 80/100 | |
3rd |  Sana Biotechnology 2018, Seattle (United States), Public | Developer of engineered cell therapies for treating various human diseases | $821M | 74/100 | |
4th | Ideaya Biosciences 2015, San Francisco (United States), Public | Developer of oncology-focused precision medicine using molecular diagnostics | $157M | 73/100 | |
5th | Sutro Biopharma 2003, United States, Public | Developer of antibody-based therapeutics for cancer therapy | $175M | 72/100 | |
6th | Senti Bio 2016, San Francisco (United States), Public | Developer of cell and gene therapies for patients living with incurable diseases | $158M | 72/100 | |
7th | Syndax 2005, Waltham (United States), Public | Developer of targeted therapies for the treatment of cancer | $198M | 72/100 | |
8th | Developer of T-cell therapies for the treatment of cancer | $49.8M | 71/100 | ||
9th |  Moderna 2010, Cambridge (United States), Public | Developer of mRNA-based therapeutics for a wide range of diseases | $2.78B | 71/100 | |
10th | C4 Therapeutics 2016, Cambridge (United States), Public | Developer of small molecule drugs for treating cancer | $223M | 71/100 | |
1076th | Citius Oncology 2023, Cranford (United States), Public | Developer of targeted oncology therapies, including FDA-approved treatment for CTCL | - | - | 41/100 |
Get insights and benchmarks for competitors of 2M+ companies! Sign up today!Looking for more details on Citius Oncology's competitors? Click here to see the top ones
Citius Oncology's Investments and acquisitions
Citius Oncology has made no investments or acquisitions yet.
Reports related to Citius Oncology
Here is the latest report on Citius Oncology's sector:
News related to Citius Oncology
Filter this listMedia has covered Citius Oncology for a total of 15 events in the last 1 year, 9 of them have been about company updates.
•
Citius Oncology Reports Fiscal Third Quarter 2026 Financial Results and Business UpdatePR Newswire•Aug 15, 2026•Citius Oncology
•
Citius Oncology Reports Strong Commercial Momentum for its Cancer Treatment LYMPHIRPR Newswire•Aug 05, 2026•Citius Oncology
•
Citius Oncology (NASDAQ:CTOR) Trading Up 11.5% – What’s Next?ZolmaxNews•Jul 01, 2026•Citius Oncology
•
•
Citius Oncology Announces Phase 1 Data on LYMPHIR Before CAR-T TherapyPR Newswire•Mar 04, 2026•Citius Oncology
•
Citius Oncology Announces First Revenue Following LYMPHIR™ LaunchPR Newswire•Feb 13, 2026•Citius Oncology
•
SHAREHOLDER ALERT: Purcell & Lefkowitz LLP Announces Shareholder Investigation of Citius Oncology, Inc.PR Newswire•Jan 05, 2026•Citius Oncology, Purcell & Lefkowitz
•
Citius Oncology Closes $18 Million Direct Offering and Private PlacementPR Newswire•Dec 11, 2025•Citius Oncology, H.C. Wainwright
•
Citius Oncology Expands LYMPHIR Distribution to Turkey and Middle East with Er-Kim AgreementBenzinga•Dec 04, 2025•Erkim, Citius Oncology
•
Get curated news about company updates, funding rounds, M&A deals and others. Sign up today!Are you a Founder ?
FAQs about Citius Oncology
Explore our recently published companies
- Johnny Guielebo - Founder - Sao Paulo based, 2026 founded, Stealth company
- Joshua Rubin - Founder & Engineer - Israel based, 2026 founded, Stealth company
- Sébastien Chauvelle - Co-founder & COO - France based, 2026 founded, Stealth company
- Ashley Rae Pittson - Co-Founder and CEO - United States based, 2023 founded, Stealth company
- Cecilia Zhang - Founder - United States based, 2026 founded, Stealth company
- Asmita Sharma - Lead Partner - India based, 2026 founded, Stealth company
